These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2199037)

  • 21. On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence for mediation by autoreceptors localized on nerve terminals.
    Westerink BH; de Vries JB
    Neurosci Lett; 1989 Apr; 99(1-2):197-202. PubMed ID: 2526308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of peripheral dopamine receptor and alpha-adrenoceptor blocking activity of sulpiride.
    Barrett RJ; Ginos JZ; Lokhandwala MF
    Eur J Pharmacol; 1982 Apr; 79(3-4):273-81. PubMed ID: 6124431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine D-2 auto- and postsynaptic receptors in the nigrostriatal system of the rat brain: localization by quantitative autoradiography with [3H]sulpiride.
    Filloux FM; Wamsley JK; Dawson TM
    Eur J Pharmacol; 1987 Jun; 138(1):61-8. PubMed ID: 3113982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blockade of dopamine receptors in the renal vasculature by isomers of flupenthixol and sulpiride.
    Schmidt M; Imbs JL; Giesen EM; Schwartz J
    J Cardiovasc Pharmacol; 1983; 5(1):86-9. PubMed ID: 6186865
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic autoreceptor blockade and neuroleptic-induced dopamine receptor hypersensitivity.
    Gordon JH; Clopton JK; Curtin JC; Koller WC
    Pharmacol Biochem Behav; 1987 Feb; 26(2):223-8. PubMed ID: 3575347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of effects of tiapride and sulpiride on D-1, D-2, D-3 and D-4 subtypes of dopamine receptors in rat striatal and bovine caudate nucleus membranes.
    Arima T; Samura N; Nomura Y; Segawa T
    Jpn J Pharmacol; 1986 Jul; 41(3):419-23. PubMed ID: 3761757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of adenylate cyclase inhibition in dopamine autoreceptor regulation of tyrosine hydroxylase in rat nucleus accumbens.
    Onali P; Olianas MC
    Neurosci Lett; 1989 Jul; 102(1):91-6. PubMed ID: 2571111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereoselective blockade of cerebral dopamine receptors by sulpiride and sultopride [proceedings].
    Clow A; Jenner P; Marsden CD; Reavill C; Theodorou A
    Br J Pharmacol; 1979 Nov; 67(3):433P. PubMed ID: 497556
    [No Abstract]   [Full Text] [Related]  

  • 29. Evidence that the stimulatory effect of neurotensin on dopamine release in rat nucleus accumbens slices is independent of dopamine D2-receptor activation.
    Reyneke L; Russell VA; Taljaard JJ
    Brain Res; 1990 Nov; 534(1-2):188-94. PubMed ID: 1981481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on tubular reabsorption].
    Agnoli GC; Andreone P; Cacciari M; Garutti C; Ikonomu E; Lenzi P
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):175-80. PubMed ID: 6704244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that systemically administered dopamine antagonists activate dopamine neuron firing primarily by blockade of somatodendritic autoreceptors.
    Pucak ML; Grace AA
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1181-92. PubMed ID: 7996424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Sulpiride (stereoisomers, racemic) and dopamine: actions and interactions on renal excretion of hydro-saline].
    Agnoli GC; Andreone P; Cacciari M; Garutti C; Ikonomu E; Lenzi P
    Boll Soc Ital Biol Sper; 1984 Jan; 60(1):181-6. PubMed ID: 6704245
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chronic cocaine treatment impairs the regulation of synaptosomal 3H-DA release by D2 autoreceptors.
    Yi SJ; Johnson KM
    Pharmacol Biochem Behav; 1990 Jul; 36(3):457-61. PubMed ID: 1974064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors.
    Alander T; Andén NE; Grabowska-Andén M
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Jun; 312(2):145-50. PubMed ID: 7402361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Possible mixed agonist--antagonist activity of D-sulpiride at dopamine receptor level in man.
    Benfenati F; Bernardi P; Cortelli P; Capelli M; Adani C; Calzà L; Agnati LF
    Neurosci Lett; 1981 Nov; 26(3):289-95. PubMed ID: 7033836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of dopamine2-receptors in mediating renal vascular response to low dose dopamine infusion in the rat.
    Seri I; Eklöf AC; Aperia A
    Acta Physiol Scand; 1987 Aug; 130(4):563-9. PubMed ID: 3630734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increase in D2 dopamine receptors in the substantia nigra after chronic (-)-sulpiride treatment.
    Stefanini E; Frau M; Gessa GL
    Brain Res; 1991 Aug; 555(2):340-2. PubMed ID: 1834311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sulpiride and the effect of dopamine on the kidney in human salt retention].
    Agnoli GC; Cacciari M; Garutti C; Lenzi P
    Boll Soc Ital Biol Sper; 1979 Feb; 55(4):311-7. PubMed ID: 552845
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the dopamine D-1 antagonist SCH 23390 and the D-2 antagonist sulpiride on saline acceptance-rejection in water-deprived rats.
    Gilbert DB; Cooper SJ
    Pharmacol Biochem Behav; 1987 Apr; 26(4):687-91. PubMed ID: 3299396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.
    Tissari AH; Rossetti ZL; Meloni M; Frau MI; Gessa GL
    Eur J Pharmacol; 1983 Aug; 91(4):463-8. PubMed ID: 6413231
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.